Journal of Neuroimmunology
Volume 218, Issue 1 , Pages 140-144, 25 January 2010

Intratumoral IL-7 delivery by mesenchymal stromal cells potentiates IFNγ-transduced tumor cell immunotherapy of experimental glioma

  • Salina Gunnarsson

      Affiliations

    • The Rausing Laboratory, BMC D14, Division of Neurosurgery, Department of Clinical Sciences, Lund University, SE-221 84 Lund, Sweden
    • Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, BMC B10, Lund University, SE-221 84 Lund, Sweden
    • Corresponding Author InformationCorresponding author. Postal address: BMC D14, The Rausing Laboratory, Division of Neurosurgery, Department of Clinical Sciences, Lund University, SE-221 84 Lund, Sweden. Tel.: +46 46 222 14 40; fax: +46 46 222 46 06.
    web address
  • ,
  • Daniel Bexell

      Affiliations

    • The Rausing Laboratory, BMC D14, Division of Neurosurgery, Department of Clinical Sciences, Lund University, SE-221 84 Lund, Sweden
    • Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, BMC B10, Lund University, SE-221 84 Lund, Sweden
  • ,
  • Andreas Svensson

      Affiliations

    • The Rausing Laboratory, BMC D14, Division of Neurosurgery, Department of Clinical Sciences, Lund University, SE-221 84 Lund, Sweden
    • Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, BMC B10, Lund University, SE-221 84 Lund, Sweden
  • ,
  • Peter Siesjö

      Affiliations

    • The Rausing Laboratory, BMC D14, Division of Neurosurgery, Department of Clinical Sciences, Lund University, SE-221 84 Lund, Sweden
  • ,
  • Anna Darabi

      Affiliations

    • The Rausing Laboratory, BMC D14, Division of Neurosurgery, Department of Clinical Sciences, Lund University, SE-221 84 Lund, Sweden
  • ,
  • Johan Bengzon

      Affiliations

    • The Rausing Laboratory, BMC D14, Division of Neurosurgery, Department of Clinical Sciences, Lund University, SE-221 84 Lund, Sweden
    • Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, BMC B10, Lund University, SE-221 84 Lund, Sweden

Received 3 September 2009; received in revised form 23 October 2009; accepted 23 October 2009. published online 16 November 2009.

Abstract 

The present study reports regression of pre-established experimental rat gliomas as a result of combining peripheral immunization using interferon gamma (IFNγ) transduced autologous tumor cells with local intratumoral delivery of interleukin 7 (IL-7) by mesenchymal stromal cells. IL-7 alone significantly decreased the tumor area and this effect was enhanced with IFNγ immunization. A higher density of intratumoral T-cells was observed in animals receiving combined therapies compared to rats receiving either cytokine alone suggesting that the therapeutic effect is dependent on a T-cell response.

Abbreviations: AEC, 3-amino-9-ethylcarbazole, α-MEM, alpha minimum essential medium, ELISA, enzyme-linked immunosorbent assay, FBS, fetal bovine serum, GBM, glioblastoma multiforme, GFP, green fluorescent protein, HPRT, hypoxanthine phosphoribosyltransferase, HTX, Mayer's Hematoxylin, IFNγ, interferon gamma, IL-7, interleukin 7, i.p., intraperitoneal, i.t., intratumoral, MNP, mononuclear phagocyte, MSC, multipotent mesenchymal stromal cell, RT-PCR, reverse transcriptase polymerase chain reaction, PBS, phosphate buffered saline, TCR, T-cell receptor

Keywords: Glioma, Rats, Mesenchymal stem cells, Interleukin-7, Interferon gamma, Immunotherapy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0165-5728(09)00432-9

doi:10.1016/j.jneuroim.2009.10.017

Journal of Neuroimmunology
Volume 218, Issue 1 , Pages 140-144, 25 January 2010